L Mosekilde
- Endocrinology, Diabetes and Metabolism top 2%
- Orthopedics and Sports Medicine top 1%
- Genetics top 5%
- Oncology top 10%
- Molecular Biology
- Co-authors
- Lars RejnmarkMoustapha KassemPia EikenJens‐Erik Beck JensenErik Fink EriksenLis StilgrenCharlotte Landbo ToftengLouise Lind Schierbeck
- Topics
- Bone health and osteoporosis research (19 papers)Parathyroid Disorders and Treatments (16 papers)Bone health and treatments (10 papers)
- Partner nations
- DenmarkGermanyUnited States
In The Last Decade
L Mosekilde
46 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Endocrinology, Diabetes and Metabolism 751
- Orthopedics and Sports Medicine 641
- Genetics 483
- Oncology 440
- Molecular Biology 405
Countries citing papers authored by L Mosekilde
This map shows the geographic impact of L Mosekilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Mosekilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Mosekilde more than expected).
Fields of papers citing papers by L Mosekilde
This network shows the impact of papers produced by L Mosekilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Mosekilde. The network helps show where L Mosekilde may publish in the future.
Co-authorship network of co-authors of L Mosekilde
This figure shows the co-authorship network connecting the top 25 collaborators of L Mosekilde. A scholar is included among the top collaborators of L Mosekilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Mosekilde. L Mosekilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trialbreakdown → | 473 |
| 3 | 23 | |
| 4 | 8 | |
| 5 | 58 | |
| 6 | 108 | |
| 7 | 12 | |
| 8 | 64 | |
| 9 | 54 | |
| 10 | 17 | |
| 11 | 31 | |
| 12 | 34 | |
| 13 | 35 | |
| 14 | 178 | |
| 15 | Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover. | 13 |
| 16 | 114 | |
| 17 | 13 | |
| 18 | 1 | |
| 19 | [Hormonal regulation of bone remodeling]. | 1 |
| 20 | [Treatment with sodium fluoride, calcium phosphate and vitamin D2 in spinal osteoporosis. Effect on calcium balance, calcium metabolism, bone remodelling, and side effects]. | 1 |
About L Mosekilde
L Mosekilde is a scholar working on Nephrology, Orthopedics and Sports Medicine and Endocrinology, Diabetes and Metabolism, having authored 46 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (19 papers), Parathyroid Disorders and Treatments (16 papers) and Bone health and treatments (10 papers). The work is most often cited by research in Orthopedics and Sports Medicine (641 citations), Endocrinology, Diabetes and Metabolism (751 citations) and Nephrology (232 citations). L Mosekilde has collaborated with scholars based in Denmark, Germany and United States. Frequent co-authors include Lars Rejnmark, Moustapha Kassem, Pia Eiken, Jens‐Erik Beck Jensen, Erik Fink Eriksen, Lis Stilgren, Charlotte Landbo Tofteng, Louise Lind Schierbeck, Lars Køber and Peter Vestergaard. Their work appears in journals such as Endocrinology, BMJ and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.